Carter et al., New Drugs in Cancer Chemotherapy, pp. 1-2 (1981). |
Halnan, Treatment of Cancer, p. 80 (1982). |
Hoshi et al., Farumashia, vol. 9, No. 7, pp. 464-468 (1973) and English translation of pertinent portions. |
Oslo, Remington's Pharmaceutical Sciences, 16th Ed., pp. 1081-1082, Chapter 62 (1980). |
Nodine et al., Animal and Clinical, Pharmacologic Techniques in Drug Evaluation, p. 632 (1964). |
Dukes, Side Effects of Drugs Annual I, p. 336 (1977). |
Holland et al., Cancer Medicine, pp. 675-675 (1973). |
Laurence et al., Evaluation of Drug Activities: Pharmacometrics, vol. 2, p. 842 (1964). |
Siegler et al., Animal and Clinical, Pharmacologic Techniques in Drug Evaluation, vol. 2, pp. 830, 834 (1967). |
Oslo et al., The United States Dispensatory, 27th Ed., pp. 377-378, 527-528 (1973). |
Baker et al., Physicians' Desk Reference, 32nd Ed., p. 1387 (1978). |
Grollman et al., Pharmacology and Therapeutics, pp. 669-670 (1970). |